Hepatites pós-transfusionais na cidade de Campinas, SP, Brasil: II. Presença dos anticorpos anti-HBc e anti-HCV em candidatos a doadores de sangue e ocorrência de hepatites pós-transfusionais pelo vírus C nos receptores de sangue ou derivados
作者： Fernando Lopes Gonçales Júnior , Rogério de Jesus Pedro , Luiz Jacintho da Silva , Raquel Silveira Bello Stucchi Boccato , Neiva Sellan Lopes Gonçales
DOI: 10.1590/S0036-46651993000100009
关键词:
摘要: We have analysed anti-HBc and anti-HCV antibodies in serum samples from 799 donors which had their blood or derivates transfused to 111 recipients. Anti-HBc were reactive respectively 9 2.1% of the tested. observed that among recipients, 44 received at least one positive unit 67 been only with negative anti-HBc, units. The risk developing hepatitis C virus was 4.5 times higher for recipients who unit. If test made serological screening, about 56% HCV cases could avoided. population reacting anti-HCV, presented a 29 this hepatitis, as compared all Testing would avoid 79% post-transfusional cases. Brazilian candidates seem be carriers either simultaneously sequentially B C, since 44.4% also anti-HBc. screening must indicated order prevent transmission our community.
sci-hub.se 参考文章(28)
R.G. Knodell, M.E. Conrad, J.L. Dienstag, C.J. Bell, Etiological Spectrum of Post-Transfusion Hepatitis Gastroenterology. ,vol. 69, pp. 1278- 1285 ,(1975) , 10.1016/S0016-5085(19)32325-X
Y.E. Cossart, S. Kirsch, S.L. Ismay, Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study. The Lancet. ,vol. 319, pp. 208- 213 ,(1982) , 10.1016/S0140-6736(82)90770-X
Jay H. Hoofnagle, Leonard B. Seeff, Zelma Buskell Bales, Hyman J. Zimmerman, , Type B Hepatitis after Transfusion with Blood Containing Antibody to Hepatitis B Core Antigen New England Journal of Medicine. ,vol. 298, pp. 1379- 1383 ,(1978) , 10.1056/NEJM197806222982502
Harvey J. Alter, Robert H. Purcell, James W. Shih, Jacqueline C. Melpolder, Michael Houghton, Qui-Lim Choo, George Kuo, Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis The New England Journal of Medicine. ,vol. 321, pp. 1494- 1500 ,(1989) , 10.1056/NEJM198911303212202
JH Hoofnagle, Posttransfusion hepatitis B. Transfusion. ,vol. 30, pp. 384- 386 ,(1990) , 10.1046/J.1537-2995.1990.30590296367.X
Harvey J. Alter, Donor Transaminase and Recipient Hepatitis JAMA. ,vol. 246, pp. 630- 634 ,(1981) , 10.1001/JAMA.1981.03320060032017
Q. Choo, G Kuo, A. Weiner, L. Overby, D. Bradley, M Houghton, Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science. ,vol. 244, pp. 359- 362 ,(1989) , 10.1126/SCIENCE.2523562
DELORIS E. KOZIOL, Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood Annals of Internal Medicine. ,vol. 104, pp. 488- 495 ,(1986) , 10.7326/0003-4819-104-4-488
HarveyJ. Alter, PaulV. Holland, AndrewG. Morrow, RobertH. Purcell, StephenM. Feinstone, Yasuo Moritsugu, CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITIS The Lancet. ,vol. 306, pp. 838- 841 ,(1975) , 10.1016/S0140-6736(75)90234-2
A PRINCE, Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. The Lancet. ,vol. 304, pp. 241- 246 ,(1974) , 10.1016/S0140-6736(74)91412-3